Idiopathic pulmonary fibrosis (IPF) is a chronic progressive fibrotic disorder of the lung parenchyma. We have demonstrated changes in IL-10 protein production by alveolar macrophages (AMs) from patients with IPF, which we hypothesise could be because of an IL-10 gene polymorphism. We have screened the coding sequence and 3 0 untranslated region of IL-10 for polymorphisms using single-standard conformational polymorphism analysis. A novel polymorphism was identified resulting in a G to A substitution of +43 nucleotides from the start codon changing glycine to arginine at amino acid 15 of the signal peptide sequence. We have introduced the signal peptide mutation into the IL-10 gene and compared secretion of the mutant and wildtype forms after transient transfection of COS-7 cells. Our studies showed that the signal peptide mutation did not have a significant effect on secretion at 24 h post-transfection (P ¼ 0.4529 by Mann-Whitney test). However, by 48 h there are significantly lower levels of mutant IL-10 (P ¼ 0.0515). There were no differences in the level of cell-associated IL-10 at either 24 or 48 h (P ¼ 0.9296 and 0.4268). We suggest that the mutation could affect the efficiency of protein translocation and signal peptide cleavage resulting in lower levels of IL-10 protein secretion.
Introduction
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disorder characterised by accumulation of inflammatory cells in the alveoli and fibrosis of the lung parenchyma. 1 The alveolar macrophage (AM) plays a central role in this process because of its ability to recruit and regulate other cell types principally via the production of cytokines and growth factors. 2 In vitro, TNF-a enhances the migration of inflammatory cells, production of inflammatory mediators, fibroblast proliferation and collagen deposition. 3 Cytokines considered to have an anti-inflammatory effect, for example IL-10, also have a regulatory role affecting TNF-a production. TNF-a itself regulates production of IL-10 so stimulating a factor that exerts a negative regulatory effect on its own production. 4 In the normal lung, IL-10 is constitutively produced at a low level representing an endogenous feedback factor for the control of the inflammatory response. 5 The aetiology of IPF is unknown, but AMs from these patients exhibit elevated levels of TNF-a relative to IL-10, suggesting that in this disease the normal homeostatic mechanisms fail to regulate the TNF-a inflammatory response 6, 7 (Freeburn R, Millar A, unpublished results). Differences in lipopolysaccharide (LPS)-induced IL-10 secretion have been related to corresponding differences in mRNA production implicating transcription as the principal mechanism in variable IL-10 production. Additionally, there is evidence to suggest that IL-10 gene haplotypes and promoter polymorphisms are associated with differential IL-10 production and that approximately 75% of interindividual variation in IL-10 production appears to be genetic. 8, 9 We have previously explored the potential relation of several known polymorphisms in the promoter region to the development of IPF. To exclude the possibility that a novel IL-10 gene mutation could be responsible for the reduced levels of IL-10 observed in IPF, DNA from patients with IPF was screened for polymorphisms in the coding sequence and 3 0 untranslated region (3 0 UTR) using single-stranded conformational polymorphism (SSCP) analysis. A novel polymorphism in the IL-10 coding region was identified. The same mutation has been identified recently by a group investigating the involvement of IL-10 in myocardial infarction. 10 In that study, the polymorphism was relatively rare. There were no homozygotes and heterozygotes were as common in patients with myocardial infarction as in the control group. 10 We hypothesised that this mutation could have a functional effect connected to altered levels of IL-10 secretion. To test this hypothesis, we have introduced the mutation into the IL-10 gene to compare secretion of the normal and mutant forms of IL-10.
Results
SSCP analysis of IL-10 coding sequence SSCP analysis was carried out on the coding sequence of IL-10 using genomic DNA from 96 patients with IPF. The IL-10 gene contains five exons that make up the coding sequence of IL-10 ( Figure 1 ). For each of the first four smaller exons, PCR primers that annealed to intronic sequence on either side of the exon were designed to amplify the entire exon : including the recognised exon intron boundaries. A further six pairs of overlapping PCR primers were used to screen the larger fifth exon that includes the translational stop codon and regulatory 3 0 untranslated region of IL-10. No abnormalities were detected by SSCP analysis in any patient in fragments 2-8 and 10. In fragment 1 (nucleotides 3908-4279), which includes the translation start codon, signal peptide sequence and part of the promoter region, three patients gave a similar abnormal SSCP pattern under all electrophoresis conditions. This abnormality was most obvious in gel condition A, with two extra bands clearly visible (Figure 2a ). The patient PCR products were cloned and clones containing the abnormality selected by comparing their SSCP patterns with the original patient PCR. Sequencing of the clones revealed a G to A base substitution at nucleotide 4099 of the gene sequence or +43 nucleotides from the start codon. This alteration creates a site for the restriction enzyme Mae1 (c/tag). Digestion of a fragment 1 PCR product by Mae1 gives three bands of 173, 117 and 8 bp with the polymorphism present compared to two bands of 290 and 8 bp when it is not present. Digestion of PCR products from the three patients confirmed that all were heterozygous for this polymorphism (Figure 2b ). Subsequent analysis of the normal controls for this polymorphism revealed that three of the 96 samples were heterozygous for this base substitution. The nucleotide substitution falls in the first base of a codon located in the signal peptide sequence of IL-10 and changes the glycine (Gly) residue at this position to an arginine (Arg). As this polymorphism is less than 1300 bp from the IL-10.G microsatellite and the three SNPs analysed, the possibility of genetic linkage was investigated. Analysis of the genotypes of these three patients showed that two were homozygous and one heterozygous for the ATA haplotype, suggesting that this new polymorphism is associated with this haplotype.
Cloning and characterisation of the IL-10 signal peptide mutation The human IL-10 coding sequence was isolated by PCR from the vector pH5C and cloned into the eukaryotic gene expression vector pcDNA3.1/V5/His-TOPO to yield pcDNA3.1/V5/His-IL-10. This vector contains the CMV promoter for high-level constitutive expression in eukaryotic cells plus a C-terminal peptide containing the V5 epitope and 6 Â HIS tag for ease of protein detection and purification. IL-10 coding sequence containing the signal peptide mutation was generated by exchanging part of the normal IL-10 signal peptide with its mutated equivalent. To check for expression and secretion of the normal and mutant IL-10 in eukaryotic cells, pcDNA3.1/ V5/His-IL-10 and pcDNA3.1/V5/His-mutIL-10 were transfected into COS-7 cells. COS-7 cells do not produce detectable levels of IL-10 protein by ELISA. After 24 h incubation, the cell culture supernatant was analysed by ELISA for the presence of IL-10. Additionally, IL-10 was immunoprecipitated from a whole-cell lysate prepared from the transfected cells. Aliquots of whole-cell lysate, immunoprecipitated protein and cell culture supernatant were examined by SDS-PAGE and Western blotting with the anti-V5 HRP conjugated monoclonal antibody. This antibody binds to the V5 epitope from pcDNA3.1/V5/ His-TOPO, which is expressed at the C-terminus of the normal and mutant IL-10 cloned in this vector. The normal and mutant IL-10 protein bands are clearly visible in the immunoprecipitated protein and cell culture supernatant samples, but are not visible in whole-cell lysate because the levels of expressed protein are below the detection limits of the anti-V5 antibody ( Figure 3 ). As expected, no bands are visible in the untransfected COS-7 cell samples. Presence of the normal and mutant IL-10 protein secreted into the culture supernatant was confirmed by the ELISA results. The mean levels of normal and mutant IL-10 produced by the COS-7 cells were 37 and 30 ng/ml cell culture supernatant, respectively. These results demonstrate that the normal and mutant IL-10 gene constructs are expressed in COS-7 cells upon transient transfection and that the signal peptide mutation did not prevent IL-10 secretion.
Relative levels of normal and mutant IL-10 secretion in transiently transfected COS-7 cells Although the mutation in the signal peptide does not prevent secretion of IL-10, it could have an effect on the efficiency of protein processing and hence the levels of protein secreted. In order to address this question, the normal and mutated IL-10 gene constructs were cotransfected into COS-7 cells with the vector pGL3-CONTROL. Analysis of the constitutive expression of Firefly luciferase expressed from pGL3-CONTROL relative to secreted IL-10 allows the level of IL-10 to be normalised for factors affecting efficiency of DNA transfection into COS-7 cells. The level of IL-10 in cell culture supernatants and luciferase in whole-cell lysates was assayed at 24 and 48 h post-transfection ( Figure 4 ). The level of IL-10 protein secreted from cells transfected with the pcDNA3.1/V5/His-mutIL-10 does not differ significantly from that produced by cells transfected with pcDNA3.1/V5/His-IL-10 at 24 h (P ¼ 0.4529 using Mann-Whitney test). However, there is a significant difference at 48 h post-transfection (P ¼ 0.0515 using Mann-Whitney test). This indicates that the signal peptide mutation may affect the efficiency of protein secretion. The level of cell-associated IL-10 was quantified by densitometry of IL-10 immunoprecipitated from whole-cell lysate and analysed by Western blotting with the anti-V5 antibody ( Figure 5 ). There was no significant difference in the level of cell-associated IL-10 measured at 24 and 48 h (P ¼ 0.9296 and 0.4268 using MannWhitney test). Therefore, the overall levels of mutated IL-10 protein production appear to be the same as those of normal IL-10 in the transfected cells. Discussion IL-10 is an important regulator of TNF-a and therefore of the immune response in the human lung. In the normal human lung, AMs constitutively produce low levels of IL-10 in their role as mediators of the host defence response, and this protein is upregulated by both LPS stimulation and TNF-a. The relation between IL-10 and TNF-a has been extensively investigated in numerous inflammatory disorders including IPF, where several studies have shown increased TNF-a in IPF despite evidence suggesting that IL-10 is also increased in these patients 6, 7 (Freeburn R, Millar A, unpublished data). In a previous study we showed using semiquantitative PCR that expression of IL-10 mRNA was significantly increased in AMs from patients with IPF compared to controls. Several reports provide evidence to suggest that the level of IL-10 production can be linked to polymorphic variation in the 5 0 flanking region of the IL-10 gene, which controls transcription. 8, 9 However, the increased presence of high IL-10 producing haplotypes in IPF does not explain our findings, which suggest that endogenous IL-10 from patients with IPF is ineffective in the homeostatic control of TNF-a in IPF (Freeburn R, Millar A, unpublished data). To exclude the possibility of a mutation in either the coding sequence or 3 0 UTR of the IL-10 gene altering production, secretion or function of IL-10, we screened this region of the gene using SSCP in our IPF patients.
Nine sets of PCR primers were used in the SSCP analysis to screen the coding sequence and 3 0 UTR of the IL-10 gene. In fragment 1 (nt 3908-4279), which includes the translation start codon, signal peptide sequence and part of the promoter region, three patients were found to be heterozygous for a G to A base substitution at nucleotide 4099 of the gene sequence or +43 nucleotides from the start codon. As this polymorphism is less than 1300 bp from the IL-10.G microsatelite and the three SNPs analysed, the possibility of genetic linkage was investigated. Analysis of the genotypes of these three patients showed that two were homozygous and one heterozygous for the IL10.G9-ATA haplotype, suggesting that this new polymorphism is associated with this haplotype. Subsequent analysis of the normal controls revealed that three of the 96 samples were heterozygous for this base substitution, indicating that this alteration is unlikely to be disease specific.
This polymorphism lies in the first base of a codon and the G to A substitution changes the glycine to an arginine residue at amino acid 15 of the signal peptide sequence. The same mutation was also identified by a group investigating the involvement of 1L-10 in myocardial infarction. 10 We went on to investigate the potential functional effects of this polymorphism. We transiently transfected COS-7 cells with the normal and signal peptide mutated forms of the IL-10 gene. Our studies have shown that the signal peptide mutation does not have a significant effect on the level of cell-associated IL-10 protein at either 24 or 48 h post-transfection. However, analysis of IL-10 secreted into the culture medium revealed that there were significantly lower levels of the signal peptide mutant at 48 h than the normal protein. There was no significant difference at 24 h post-transfection. Changing the overall hydrophobicity and distinct structure of the signal peptide could have an effect on translocation and signal peptide processing.
Signal sequences are responsible for targeting newly synthesized proteins to the endoplasmic reticulum in eukaryotic cells. The characteristic feature of signal sequences is the hydrophobic core, which usually contains between six and 15 amino acids. Analysis has shown that this hydrophobic region is required for targeting and membrane insertion. On the C-terminal side of the hydrophobic core is a polar region, which contains helix breaking Pro and Gly residues as well as small uncharged residues in positions À3 and À1 that determine the site of signal peptide cleavage. The hydrophobic core is flanked on the N-terminal side by a polar region that usually has a net positive charge.
The N-terminal region contributes most to the variation in overall length. 11 Five signal sequence mutations of human-secreted proteins, namely transforming growth factor-b 1 , 12 preprovasopressin, 13 preprofactor X, 14 lysosomal acid lipase (LAL) 15 and preproparathyroid hormone (prepro-PTH) 16 have been associated with human disease. Human IL-10 has an 18 amino-acid signal sequence. The mutation substitutes positively charged Arg for polar Gly at À4 adjacent to Val at the À3 position known to be essential for signal peptidase cleavage. The positively charged Arg is also adjacent to the hydrophobic core. Our observation that the signal peptide mutation in IL-10 reduces the amount of protein secreted into the culture medium at 48 h post-transfection may indicate that this mutation could affect protein translocation or the efficiency of signal peptidase cleavage.
As we have been unable to identify any IL-10 polymorphisms linked to aberrant control of the inflammatory response in IPF, it is likely that other molecules involved in IL-10 binding and signalling may be candidates. A number of examples exist in the literature in which the immunosuppressive effects of IL-10 appear to be reduced during chronic inflammation. Coexpression of TNF-a and IL-10 has been shown to occur during autoimmune diseases, inflammatory conditions and chronic infections. It has been suggested that coexpression of IL-10 with proinflammatory cytokines could indicate that the level of IL-10 is not sufficient to suppress the inflammatory response. Another possibility, however, is that in vivo expression and responsiveness of the IL-10 receptors may be altered such that even high levels of IL-10 are unable to suppress inflammation. Two recent papers on macrophage resistance to IL-10 during chronic inflammation are divided on the role of the IL-10 receptors. 17, 18 Work on a murine model of thermal injury found that macrophages became resistant to IL-10-mediated suppression of inflammation and that this response correlated with lower IL-10R expression. Studies on mice chronically infected with a retrovirus also found that persistent exposure to TNF-a in vivo appeared to reduce partially the ability of IL-10 to inhibit proinflammatory cytokine expression. In this case, expression of the IL-10R in the macrophages was intact after infection, suggesting that disruption of a signal transduction pathway may account for defective IL-10 responsiveness. The possible candidates supported by both groups are STAT3 and suppressors of cytokine signalling (SOCS). It will be interesting to see whether the IL-10 receptors or factors involved in IL-10 signalling have a similar role to play in IL-10 hyporesponsiveness in IPF.
Methods

Subjects
All patients with IPF were diagnosed according to American Thoracic Society (ATS)/European Respiratory Society (ERS) consensus classification. 19 The IPF group were all Caucasians from the United Kingdom and consisted of 96 patients (64 male, 32 female) with a median age of 66 years, range 37-86. The normal control population of 96 individuals (64 male, 32 female) were all Caucasians from the United Kingdom with no previous history of fibrosing lung disease. The normal controls had a median age of 35 years, range 18-60 years.
DNA extraction
A standard high-salt DNA extraction method was used. 20 Briefly, 5 ml of peripheral blood was collected in EDTA tubes and centrifuged for 10 min at 1300 g. The mononuclear cell layer was transferred to a conical tube and 4 ml red cell lysis buffer (0.144 M NH 4 Cl, 1 mM NaHCO 3 ) added. After 20 min, the tube was spun for 10 min at 1300 g. Red cell lysate was discarded and the white cell pellet resuspended in 1.5 ml nuclei lysis buffer (10 mM Tris-HCl, pH 8.2; 0.4 NaCl; 2 mM EDTA pH 8.0). A volume of 0.3 ml 1 Â proteinase K solution (2 mg/ml proteinase K, 1% w/v SDS, 2 mM EDTA pH 8.0) and 0.2 ml 10% w/v SDS were added, mixed and incubated for 18 h at 371C. A volume of 0.5 ml of 6 M NaCl was added and mixed for 15 s before being centrifuged for 25 min at 1300 g. The supernatant was added to 4 ml of absolute ethanol in a clean tube. The precipitated DNA was removed, resuspended in sterile water and stored at 41C.
SSCP analysis
This method exploits the fact that nucleotide mutations change the conformation of single-stranded DNA and results in altered mobilities of heat-denatured PCR products in nondenaturing polyacrylamide gels. PCR primers that give products of approximately 200-300 bp were designed to cover all exons of the entire coding sequence of IL-10 and its 3 0 untranslated region (Table 2) . PCR mixes as above (25 ml) were amplified for 35 cycles. An equal volume of denaturing solution (95% formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol) was added to each amplicon and the samples denatured at 951C for 5 min and placed on ice immediately. A volume of 10 ml was loaded on MDE high-resolution polyacrylamide triple wide minigel in 1 Â TBE. To maximise polymorphic detection efficiency three gel conditions were used: (A) 0.5% MDE, 41C, 225 V for 120 min, (B) 0.75% MDE, room temperature, 175 V for 180 min, (C) 0.5% MDE with 5% glycerol, room temperature, 150 V for 180 min. After electrophoresis the gel was stained in 1 Â SYBR Gold (Molecular probes, OR, USA) and visualised on a Dark Reader transilluminator (Clare Chemical Research, Ross-on Wye, UK).
Sequencing
In order to identify the nucleotide alteration responsible for SSCP abnormalities, PCR products were directly cloned using the pGEM-T vector system (Promega, WI, USA). Clones containing the abnormalities were selected by comparison with the original PCR product using SSCP. The positive colonies were purified using Wizard Plus SV minipreps (Promega, WI, USA) and sequenced on an ABI Prism automated sequencer. When available a suitable restriction enzyme digest was used to confirm abnormalities.
Cloning the IL-10 polymorphism
The human IL-10 coding sequence was amplified from plasmid pH5C (ATCC 68191) by PCR using oligonucleotides caccatgcacagctcagcactg and gtttcgtatcttcattgtcatgtagg. The PCR product was subcloned into the vector pcDNA3.1/V5/His-TOPO from the pcDNA3.1 Directional TOPO Expression Kit (Invitrogen) according to the manufacturer's instructions to produce pcDNA3.1/V5/ His-IL-10. The mutation in the IL-10 signal peptide was cloned from genomic DNA, isolated from an IPF patient. DNA spanning the mutation was amplified by PCR using oligonucleotides gaaggcatgcacagctcag and ctgaaggcatctcggagatc to produce a 152 bp fragment. After digestion with restriction endonucleases BlpI and BsgI, the fragment was ligated into pcDNA3.1/V5/His-IL-10 that had been digested with BlpI and BsgI to remove the equivalent normal signal peptide DNA from the IL-10 gene. The presence of the mutation was confirmed by digestion with MaeI. The resulting clone pcDNA3.1/V5/ His-mutIL-10 and pcDNA3.1/V5/His-IL-10 were sequenced to check their identity and integrity. Plasmid DNA was prepared using an Endofree Plasmid Maxi Kit (Qiagen).
Transient transfection
Tissue culture dishes (60 mm) were seeded with 5 Â 10 5 COS7 cells in 4 ml DMEM/10% FCS and cultured overnight at 371C in 5% CO 2 . The cells were approximately 50-80% confluent at the point of transfection. Cells were transiently transfected with plasmid DNA using FuGENE 6 Transfection Reagent (Roche) and a FuGENE : DNA ratio of 3 : 1 according to the manufacturer's instructions. COS7 cells were cotransfected with 4 mg pcDNA3.1/V5/His-IL-10 or pcDNA3.1/V5/ His-mutIL-10 and 0.5 mg pGL3-CONTROL. Untransfected cells were used as a control. After further incubation (24 or 48 h), cells and culture medium were harvested for gene expression analysis. The experiments were carried out in triplicate and samples assayed in triplicate.
Immunoprecipitation IL-10 was immunoprecipitated from approximately 0.5 ml whole-cell protein extract using l mg of antihuman/viral IL-10 antibody (Pharmingen). After incubation on a rotator at 41C for 1 h, 20 ml of Protein G PLUS-Agarose (Santa Cruz) was added and incubated on a rotator for a further hour at 41C. The agarose beads were washed three times in 1ml of ice-cold cell lysis buffer with centrifugation at 500 g for 5 min at 41C. The agarose beads were resuspended in 40 ml of SDS gel loading buffer and heated at 951C for 5 min to elute the immunoprecipitated IL-10.
Western transfer and immunoblotting
Immunoprecipitated IL-10 was electrophoresed through a 12% SDS-PAGE gel and subsequently transferred to Immobilon-P PVDF membrane (Sigma) by electroblotting. After blocking for 1 h at room temperature in TBST pH 7.5 (20 mM Tris-HCl pH 7.5, 137 mM NaCl, 0.1% Tween-20) containing 5% nonfat dried milk, the membrane was probed with Anti-V5-HRP antibody (Invitrogen) diluted 1/5000 in blocking buffer for 2 h at room temperature. After washing twice in TBST and once in TBS, antibody binding was revealed using ECL (Amersham) according to the manufacturer's instructions.
Luciferase assay
Transfection efficiency was monitored by measuring luciferase production after cotransfection of the test plasmids with the vector pGL3-Control (Promega). This vector contains the SV40 promoter and enhancer regions and the Firefly luciferase gene to allow the monitoring of transfection efficiency in many eukaryotic cell types. After incubating for the required time following transfection, cells were washed twice with PBS and then lysed on ice with 1X Reporter Lysis Buffer (Promega). The whole-cell extract was collected into an Eppendorf tube and cleared by centrifugation. Aliquots (20 ml) of the cell supernatent were assayed for luciferase activity using the Luciferase Assay System (Promega) as per the manufacturer's instructions.
IL-10 ELISA
Microtitre plates (Nunc Maxisorp) were coated overnight at 41C with coating antibody (Pharmingen, CA, USA). The following day diluted samples and standards were added after a 2 h blocking stage. After 2 h at 371C, the plates were washed and biotinylated IL-10 antibody (Pharmingen) was added for a further 1 h incubation. The plates were then washed and 1 : 400 avidin peroxidase was added for a further 30 min. A volume of 100 ml of tetramethyl benzidine substrate (TMB) (Biostat diagnostics, UK) was then added to each well. The colour reaction was stopped by the addition of 1 M sulphuric acid and the plates were read at 450 nm on a plate reader (Dynatech).
Statistics
Data were analysed using MINITAB statistical analysis package. The gene frequency data from the heteroduplex analysis were analysed using a standard 2 Â 2w 2 test. The genotype and haplotype frequencies of the polymorphisms in the IPF patients were compared to the normal control data. The data from the transfection studies were analysed using the Mann-Whitney test. In both tests, a P-value of 0.05 was considered to be statistically significant.
